Glucose-dependent insulinotropic polypeptide regulates dipeptide absorption in mouse jejunum

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 305, Issue 10, 2013, Pages

  Coon, Steven D ^a,b   Schwartz, John H ^a   Rajendran, Vazhaikkurichi M ^c   Jepeal, Lisa ^a,b   Singh, Satish K ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

GLP 1; Gly Sar fluxes; Mucosal membranes; Ussing chamber; Voltage clamping

Indexed keywords

ADENOSINE 3',5' PHOSPHOROTHIOATE; CEFALEXIN; COTRANSPORTER; GASTRIC INHIBITORY POLYPEPTIDE; GASTRIC INHIBITORY POLYPEPTIDE RECEPTOR; GLUCAGON LIKE PEPTIDE 1; GLYCYLSARCOSINE; HYDROGEN; MESSENGER RNA; PROTEIN ANTIBODY; PROTON PEPTIDE COTRANSPORTER 1; RECEPTOR; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL TISSUE; APICAL MEMBRANE; ARTICLE; BASOLATERAL MEMBRANE; CONTROLLED STUDY; ILEUM; IMMUNOHISTOCHEMISTRY; INTESTINE CELL; JEJUNUM; JEJUNUM MUCOSA; MALE; MOUSE; MUCOSA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMALL INTESTINE ABSORPTION; VOLTAGE CLAMP;

GLP-1; GLY-SAR FLUXES; MUCOSAL MEMBRANES; USSING CHAMBER; VOLTAGE CLAMPING;

ABSORPTION; ANIMALS; ANTI-BACTERIAL AGENTS; CEPHALEXIN; DIPEPTIDES; GASTRIC INHIBITORY POLYPEPTIDE; GENE EXPRESSION REGULATION; GLUCAGON-LIKE PEPTIDE 1; JEJUNUM; MALE; MICE; MICE, KNOCKOUT; TISSUE CULTURE TECHNIQUES;

EID: 84887584791     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00098.2013     Document Type: Article

References (40)

1. Alpers DH. Digestion and absorption of carbohydrates and proteins. In: Physiology of the Gastrointestinal Tract (3rd ed.), edited by Johnson L. New York: Raven, 1994, p. 1723-1750.
2. Boll M, Markovich D, Weber WM, Korte H, Daniel H, Murer H. Expression cloning of a cDNA from rabbit small intestine related to proton-coupled transport of peptides, beta-lactam antibiotics and ACEinhibitors. Pflügers Arch 429: 146-149, 1994.
3. Broer S. Amino acid transport across mammalian intestinal and renal epithelia. Physiol Rev 88: 249-286, 2008.
4. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K. Bariatric surgery: a systematic review and metaanalysis. JAMA 292: 1724-1737, 2004.
5. Buhren BA, Gasis M, Thorens B, Muller HW, Bosse F. Glucosedependent insulinotropic polypeptide (GIP) and its receptor (GIPR): cellular localization, lesion-affected expression, and impaired regenerative axonal growth. J Neurosci Res 87: 1858-1870, 2009.
6. Campbell JE, Drucker DJ. Pharmacology, physiology, and mechanisms of incretin hormone action. Cell Metab 17: 819-837, 2013.
7. Chen M, Singh A, Xiao F, Dringenberg U, Wang J, Engelhardt R, Yeruva S, Rubio-Aliaga I, Nassl AM, Kottra G, Daniel H, Seidler U. Gene ablation for PEPT1 in mice abolishes the effects of dipeptides on small intestinal fluid absorption, short-circuit current, and intracellular pH. Am J Physiol Gastrointest Liver Physiol 299: G265-G274, 2010.
8. Cho YM, Kieffer TJ. K-cells and glucose-dependent insulinotropic polypeptide in health and disease. Vitam Horm 84: 111-150, 2011.
9. Coon S, Schwartz JH, Singh SK. GIP activation of signaling pathways traffics Pept1 to the apical membrane of intestinal epithelial cells. Gastroenterology 144: S200, 2013.
10. Daniel H, Kottra G. The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology. Pflügers Arch 447: 610-618, 2004.
11. Das UN. Obesity: genes, brain, gut, environment. Nutrition 26: 459-473, 2010.
12. Drucker DJ. The biology of incretin hormones. Cell Metab 3: 153-165, 2006.
13. Dulloo AG, Montani JP. Body composition, inflammation and thermogenesis in pathways to obesity and the metabolic syndrome: an overview. Obes Rev 13, Suppl 2: 1-5, 2012.
14. Elliott RM, Morgan LM, Tredger JA, Deacon S, Wright J, Marks V. Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns. J Endocrinol 138: 159-166, 1993.
15. Fei YJ, Sugawara M, Liu JC, Li HW, Ganapathy V, Ganapathy ME, Leibach FH. cDNA structure, genomic organization, and promoter analysis of the mouse intestinal peptide transporter PEPT1. Biochim Biophys Acta 1492: 145-154, 2000.
16. Furman B, Ong WK, Pyne NJ. Cyclic AMP signaling in pancreatic islets. Adv Exp Med Biol 654: 281-304, 2010.
17. Harada N, Yamada Y, Tsukiyama K, Yamada C, Nakamura Y, Mukai E, Hamasaki A, Liu X, Toyoda K, Seino Y, Inagaki N. A novel GIP receptor splice variant influences GIP sensitivity of pancreatic cells in obese mice. Am J Physiol Endocrinol Metab 294: E61-E68, 2008.
18. Herrmann C, Goke R, Richter G, Fehmann HC, Arnold R, Goke B. Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients. Digestion 56: 117-126, 1995.
19. Holst JJ, Gromada J, Nauck MA. The pathogenesis of NIDDM involves a defective expression of the GIP receptor. Diabetologia 40: 984-986, 1997.
20. Kennedy DJ, Leibach FH, Ganapathy V, Thwaites DT. Optimal absorptive transport of the dipeptide glycylsarcosine is dependent on functional Na/H exchange activity. Pflügers Arch 445: 139-146, 2002.
21. Langenberg C, Savage DB. An amino acid profile to predict diabetes? Nat Med 17: 418-420, 2011.
22. Leibach FH, Ganapathy V. Peptide transporters in the intestine and the kidney. Annu Rev Nutr 16: 99-119, 1996.
23. Liang R, Fei YJ, Prasad PD, Ramamoorthy S, Han H, Yang-Feng TL, Hediger MA, Ganapathy V, Leibach FH. Human intestinal H/peptide cotransporter. Cloning, functional expression, and chromosomal localization. J Biol Chem 270: 6456-6463, 1995.
24. Ma K, Hu Y, Smith DE. Influence of fed-fasted state on intestinal PEPT1 expression and in vivo pharmacokinetics of glycylsarcosine in wild-type and Pept1 knockout mice. Pharm Res 29: 535-545, 2011.
25. Meier JJ. The contribution of incretin hormones to the pathogenesis of type 2 diabetes. Best Pract Res Clin Endocrinol Metab 23: 433-441, 2009.
26. Miyawaki K, Yamada Y, Ban N, Ihara Y, Tsukiyama K, Zhou H, Fujimoto S, Oku A, Tsuda K, Toyokuni S, Hiai H, Mizunoya W, Fushiki T, Holst JJ, Makino M, Tashita A, Kobara Y, Tsubamoto Y, Jinnouchi T, Jomori T, Seino Y. Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med 8: 738-742, 2002.
27. Nduati V, Yan Y, Dalmasso G, Driss A, Sitaraman S, Merlin D. Leptin transcriptionally enhances peptide transporter (hPepT1) expression and activity via the cAMP-response element-binding protein and Cdx2 transcription factors. J Biol Chem 282: 1359-1373, 2007.
28. Nguyen HT, Charrier-Hisamuddin L, Dalmasso G, Hiol A, Sitaraman S, Merlin D. Association of PepT1 with lipid rafts differently modulates its transport activity in polarized and nonpolarized cells. Am J Physiol Gastrointest Liver Physiol 293: G1155-G1165, 2007.
29. O'Brien PE. Bariatric surgery: mechanisms, indications and outcomes. J Gastroenterol Hepatol 25: 1358-1365, 2010.
30. Rexhepaj R, Rotte A, Kempe DS, Sopjani M, Foller M, Gehring EM, Bhandaru M, Gruner I, Mack AF, Rubio-Aliaga I, Nassl AM, Daniel H, Kuhl D, Lang F. Stimulation of electrogenic intestinal dipeptide transport by the glucocorticoid dexamethasone. Pflügers Arch 459: 191-202, 2009.
31. Rubino F, Moo TA, Rosen DJ, Dakin GF, Pomp A. Diabetes surgery: a new approach to an old disease. Diabetes Care 32, Suppl 2: S368-S372, 2009.
32. Rubio-Aliaga I, Daniel H. Peptide transporters and their roles in physiological processes and drug disposition. Xenobiotica 38: 1022-1042, 2008.
33. Singh SK, Bartoo AC, Krishnan S, Boylan MO, Schwartz JH, Michael Wolfe M. Glucose-dependent insulinotropic polypeptide (GIP) stimulates transepithelial glucose transport. Obesity (Silver Spring) 16: 2412-2416, 2008.
34. Usdin TB, Mezey E, Button DC, Brownstein MJ, Bonner TI. Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain. Endocrinology 133: 2861-2870, 1993.
35. Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, McCabe E, Lewis GD, Fox CS, Jacques PF, Fernandez C, O'Donnell CJ, Carr SA, Mootha VK, Florez JC, Souza A, Melander O, Clish CB, Gerszten RE. Metabolite profiles and the risk of developing diabetes. Nat Med 17: 448-453, 2011.
36. Wu G. Amino acids: metabolism, functions, nutrition. Amino Acids 37: 1-17, 2009.
37. Wu T, Rayner CK, Jones K, Horowitz M. Dietary effects on incretin hormone secretion. Vitam Horm 84: 81-110, 2011.
38. Yip RG, Boylan MO, Kieffer TJ, Wolfe MM. Functional GIP receptors are present on adipocytes. Endocrinology 139: 4004-4007, 1998.
39. Yip RG, Wolfe MM. GIP biology and fat metabolism. Life Sci 66: 91-103, 2000.
40. Zhong Q, Bollag RJ, Dransfield DT, Gasalla-Herraiz J, Ding KH, Min L, Isales CM. Glucose-dependent insulinotropic peptide signaling pathways in endothelial cells. Peptides 21: 1427-1432, 2000.